Molecular Targeted Therapy
"Molecular Targeted Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Treatments with drugs which interact with or block synthesis of specific cellular components characteristic of the individual's disease in order to stop or interrupt the specific biochemical dysfunction involved in progression of the disease.
Descriptor ID |
D058990
|
MeSH Number(s) |
E02.319.574
|
Concept/Terms |
Molecular Targeted Therapy- Molecular Targeted Therapy
- Molecular Targeted Therapies
- Targeted Therapies, Molecular
- Targeted Therapy, Molecular
- Therapies, Molecular Targeted
- Therapy, Molecular Targeted
- Targeted Molecular Therapy
- Molecular Therapies, Targeted
- Molecular Therapy, Targeted
- Targeted Molecular Therapies
- Therapies, Targeted Molecular
- Therapy, Targeted Molecular
|
Below are MeSH descriptors whose meaning is more general than "Molecular Targeted Therapy".
Below are MeSH descriptors whose meaning is more specific than "Molecular Targeted Therapy".
This graph shows the total number of publications written about "Molecular Targeted Therapy" by people in this website by year, and whether "Molecular Targeted Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 1 | 0 | 1 |
2009 | 0 | 1 | 1 |
2010 | 8 | 16 | 24 |
2011 | 28 | 57 | 85 |
2012 | 35 | 46 | 81 |
2013 | 36 | 55 | 91 |
2014 | 42 | 62 | 104 |
2015 | 49 | 67 | 116 |
2016 | 39 | 76 | 115 |
2017 | 33 | 87 | 120 |
2018 | 51 | 64 | 115 |
2019 | 33 | 77 | 110 |
2020 | 27 | 69 | 96 |
2021 | 15 | 33 | 48 |
2022 | 1 | 14 | 15 |
2023 | 2 | 4 | 6 |
2024 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Molecular Targeted Therapy" by people in Profiles.
-
A generalized calibrated Bayesian hierarchical modeling approach to basket trials with multiple endpoints. Biom J. 2024 Mar; 66(2):e2300122.
-
Precision Oncology in Hepatopancreatobiliary Cancer Surgery. Surg Oncol Clin N Am. 2024 Apr; 33(2):343-367.
-
EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer. Int J Mol Sci. 2024 Jan 20; 25(2).
-
Tissue-Agnostic Cancer Therapy Approvals. Surg Oncol Clin N Am. 2024 Apr; 33(2):243-264.
-
The descriptive epidemiology of melanoma in Italy has changed - for the better. Ital J Dermatol Venerol. 2023 Dec; 158(6):483-492.
-
Novel Agents in Waldenstr?m Macroglobulinemia. Hematol Oncol Clin North Am. 2023 Aug; 37(4):751-760.
-
Updates in the use of targeted therapies for the treatment of cholangiocarcinoma. J Oncol Pharm Pract. 2023 Jul; 29(5):1206-1217.
-
Top advances of the year: Precision oncology. Cancer. 2023 06 01; 129(11):1634-1642.
-
Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer. Int J Mol Sci. 2023 Feb 15; 24(4).
-
Comparison of Mold Active Triazoles as Primary Antifungal Prophylaxis in Patients With Newly Diagnosed Acute Myeloid Leukemia in the Era of Molecularly Targeted Therapies. Clin Infect Dis. 2022 Oct 29; 75(9):1503-1510.